Lite Strategy (LITS) FCF Margin Growth (1y) (2017 - 2023)
Lite Strategy (LITS) FCF Margin Growth (1y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 26,102.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 869.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 769.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 4,109.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 19,111.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 811.00 |
| 10 | Lite Strategy | 35.71 Mn | 28.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 14,100.00 |
| Jun 30, 2023 | -63,959.00 |
| Mar 31, 2023 | -2,972.00 |
| Dec 31, 2022 | 2,924.00 |
| Sep 30, 2022 | -6,969.00 |
| Jun 30, 2022 | 1,261.00 |
| Mar 31, 2022 | 1,687.00 |
| Dec 31, 2021 | -10,454.00 |
| Sep 30, 2021 | 4,732.00 |
| Jun 30, 2021 | -42,168.00 |
| Mar 31, 2021 | 69,733.00 |
| Dec 31, 2020 | 107,149.00 |
| Sep 30, 2020 | 106,981.00 |
| Jun 30, 2020 | 98,570.00 |
| Mar 31, 2020 | 2,062.00 |
| Dec 31, 2019 | -117,638.00 |
| Sep 30, 2019 | 140,946.00 |
| Jun 30, 2019 | -7,956.00 |
| Mar 31, 2019 | 52,999.00 |
| Dec 31, 2018 | 146,370.00 |